Association of low to moderate levels of arsenic exposurewith risk of type 2 diabetes in bangladesh

American Journal of Epidemiology

Volumn 178, Issue 10, 2013, Pages 1563-1570

  Pan, Wen Chi ^a   Seow, Wei Jie ^a   Kile, Molly L ^b   Hoffman, Elaine B ^a   Quamruzzaman, Quazi ^c   Rahman, Mahmuder ^c   Mahiuddin, Golam ^c   Mostofa, Golam ^c   Lu, Quan ^a   Christiani, David C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c Dhaka Community Hospital   (Bangladesh)

Author keywords

Additive interaction; Arsenic; Bangladesh; Diabetes; Overweight; Smoking

Indexed keywords

ARSENIC; DRINKING WATER;

ARSENIC; BODY MASS; CONFIDENCE INTERVAL; DIABETES; DRINKING WATER; HEALTH RISK;

ADULT; ARTICLE; BANGLADESH; BODY MASS; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK FACTOR; SKIN DEFECT; SMOKING;

ADDITIVE INTERACTION; ARSENIC; BANGLADESH; DIABETES; OVERWEIGHT; SMOKING;

ADULT; ARSENIC; BANGLADESH; BODY WEIGHTS AND MEASURES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; NAILS; RISK FACTORS; SKIN DISEASES; SMOKING; SOCIOECONOMIC FACTORS; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION, CHEMICAL;

EID: 84890092874     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt195     Document Type: Article

References (32)

1. Ravenscroft P. Prediction the Global Extent of Arsenic Pollution of Groundwater and its Potential Impact on Human Health. Cambridge, United Kingdom: UNICEF; 2007.
2. Environmental Protection Agency. National primary drinking water regulations; arsenic and clarifications to compliance and new source contaminants monitoring; final rule. Fed Regist. 2001;66(14):6976-7066.
3. Lai MS, Hsueh YM, Chen CJ, et al. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol. 1994;139(5):484-492.
4. Tseng CH, Tai TY, Chong CK, et al. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: A cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect. 2000;108(9):847-851.
5. Rahman M, Tondel M, Ahmad SA, et al. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol. 1998;148(2):198-203.
6. Rahman M, Tondel M, Chowdhury IA, et al. Relations between exposure to arsenic, skin lesions, and glucosuria. Occup Environ Med. 1999;56(4):277-281.
7. Fu J,Woods CG, Yehuda-Shnaidman E, et al. Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic beta cells: Involvement of cellular adaptive response to oxidative stress. Environ Health Perspect. 2010;118(6): 864-870.
8. Paul DS, Harmon AW, Devesa V, et al. Molecular mechanisms of the diabetogenic effects of arsenic: Inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect. 2007;115(5):734-742.
9. Walton FS, Harmon AW, Paul DS, et al. Inhibition of insulindependent glucose uptake by trivalent arsenicals: Possible mechanism of arsenic-induced diabetes. Toxicol Appl Pharmacol. 2004;198(3):424-433.
10. Paul DS, Hernandez-Zavala A,Walton FS, et al. Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: Development of a mouse model for arsenic-induced diabetes. Toxicol Appl Pharmacol. 2007; 222(3):305-314.
11. Paul DS,Walton FS, Saunders RJ, et al. Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat diet. Environ Health Perspect. 2011;119(8):1104-1109.
12. Izquierdo-Vega JA, Soto CA, Sanchez-Pena LC, et al. Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite. Toxicol Lett. 2006; 160(2):135-142.
13. Del Razo LM, Garcia-Vargas GG, Valenzuela OL, et al. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: A cross-sectional study in the Zimapán and Lagunera regions in Mexico. Environ Health. 2011;10:73.
14. Steinmaus C, Yuan Y, Liaw J, et al. Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: A reanalysis. Epidemiology. 2009; 20(6):807-815.
15. Lewis DR, Southwick JW, Ouellet-Hellstrom R, et al. Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect. 1999;107(5):359-365.
16. Zierold KM, Knobeloch L, Anderson H. Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. Am J Public Health. 2004;94(11):1936-1937.
17. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, et al. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA. 2008;300(7):814-822.
18. Chen Y, Ahsan H, Slavkovich V, et al. No association between arsenic exposure from drinking water and diabetes mellitus: A cross-sectional study in Bangladesh. Environ Health Perspect. 2010;118(9):1299-1305.
19. National Research Council. Arsenic in Drinking Water: 2001 Update. Washington, DC: National Academy Press; 2001.
20. National Research Council. Arsenic in Drinking Water. Washington, DC: National Academy Press; 1999.
21. Navas-Acien A, Silbergeld EK, Streeter RA, et al. Arsenic exposure and type 2 diabetes: A systematic review of the experimental and epidemiological evidence. Environ Health Perspect. 2006;114(5):641-648.
22. Chen CJ,Wang SL, Chiou JM, et al. Arsenic and diabetes and hypertension in human populations: A review. Toxicol Appl Pharmacol. 2007;222(3):298-304.
23. Breton CV, ZhouW, Kile ML, et al. Susceptibility to arsenic-induced skin lesions from polymorphisms in base excision repair genes. Carcinogenesis. 2007;28(7): 1520-1525.
24. McCarty KM, Chen YC, Quamruzzaman Q, et al. Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ Health Perspect. 2007;115(3): 341-345.
25. Chen KL, Amarasiriwardena CJ, Christiani DC. Determination of total arsenic concentrations in nails by inductively coupled plasma mass spectrometry. Biol Trace Elem Res. 1999; 67(2):109-125.
26. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-1334.
27. Executive summary: Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(1 suppl):4S-10S.
28. Rothman KJ. Modern Epidemiology. Boston, MA: Little, Brown; 1986.
29. Assmann SF, Hosmer DW, Lemeshow S, et al. Confidence intervals for measures of interaction. Epidemiology. 1996; 7(3):286-290.
30. Seow WJ, Pan WC, Kile ML, et al. Arsenic reduction in drinking water and improvement in skin lesions: A follow-up study in Bangladesh. Environ Health Perspect. 2012; 120(12):1733-1738.
31. Islam R, Khan I, Hassan SN, et al. Association between type 2 diabetes and chronic arsenic exposure in drinking water: A cross sectional study in Bangladesh. Environ Health. 2012;11:38.
32. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765): 557-567.